Fields, 74, spent 35 years navigating the regulatory maze meant to ensure that any ... she took a full-time transcription gig at what she was told was a “little biotech company.” ...

Mike Sterner grew up an MSU fan in a house of Wolverines, and his dedication to the team is evident not only in his gameday ...

In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...

Amy Husmann became a Beta-Tester for TranscribeGlass during summer 2024. Husmann, who is completely deaf in one ear and has ...

MaizeCODE is a genomic project analyzing the genetic basis of maize domestication. Researchers identified key regulatory ...

The origins of human language remain mysterious. Are we the only animals truly capable of complex speech? Are Homo sapiens ...

Check out who the newest group of castaways has good and not-so-good reads on while breaking down their competition.

Yeah, so in talking with more than a dozen engineers and academic researchers, my co-reporter Hilka Shellman and I found that this particular AI powered transcription tool makes things up that can ...

“It’s like trying to find your way through a maze the size of Earth. These are very long paths that you have to test out, and there’s only one path that works.” To that end, the new Caltec ...

“Punjab, a traditionally maize-growing state, has the potential to seize this opportunity and thereby replace paddy and move towards the much-needed crop diversification. During pre-Green ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...